| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| SRY |
Q05066
|
sex determining region Y
|
Transcription factor
|
|
0.456 |
0.808 |
| NEFL |
P07196
|
neurofilament light
|
|
|
0.488 |
0.769 |
| C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| ATP6 |
P00846
|
ATP synthase F0 subunit 6
|
Transporter
|
|
0.541 |
0.731 |
| MIR17HG |
Q75NE6
|
miR-17-92a-1 cluster host gene
|
|
|
0.483 |
0.808 |
| ND6 |
P03923
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
|
0.544 |
0.808 |
| MIR132 |
|
microRNA 132
|
|
|
0.485 |
0.846 |
| CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| MIR148A |
|
microRNA 148a
|
|
|
0.506 |
0.846 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |